Follow the GENETIC SIGNATURES LIMITED share price and the full directors' dealings record of the company, a listed issuer based in Australia. Shares trade on the AU market, under the oversight of ASX. Market capitalisation: €21.6m. The latest transaction was filed on 1 September 2026 (Other). Among the most active insiders: Caroline Waldron. The full history is free.
6
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 26,437 of 29,063 companies
20.8
score / 100
Value
2
Quality
39
FCF yld-61%
Earn yld-93%
EV/EBITDA·
ROE-33%
Gross mgn49%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.